Data de publicação: 29/04/2020 - 12:19
Published in the JAMA Network Open, the initial results of the CloroCovid-19 trial show that patients with severe Covid-19 should not take high doses of chloroquine. The trial, whose goal is to assess the efficacy of two different dosages of the drug and has analised 81 patients with SARS (severe acute respiratory syndrome), is being led by more than 70 researchers, post-graduation students, and collaborators from renowned scientific...
Notícias
Data de publicação: 28/04/2020 - 19:01
The Oswaldo Cruz Foundation (Fiocruz) will be producing 11 million tests for the Ministry of Health (MS) by September. The Foundation began supplying the tests on March 4. The goal of the first agreement was to produce 25,000 tests for Sars-CoV-2, to be used in the National Influenza Centers (Oswaldo Cruz Institute - IOC/Fiocruz, Adolfo Lutz Institute and Evandro Chagas Institute).
Also in March, as the number of cases associated to the...
Notícias
Data de publicação: 28/04/2020 - 18:43
The number of deaths caused by Covid-19 has doubled every 5 days in Brazil, on average. In the United States and in Ecuador, countries with high dissemination rates, the interval necessary for this duplication is an average of 6 days. In Italy and in Spain, 8 days.
This is one of the figures released by the most recent technical paper of MonitoraCovid-19, a system that groups and provides data on the pandemic of the new coronavirus in...
Notícias
Data de publicação: 28/04/2020 - 17:59
A group of researchers of the Oswaldo Cruz Foundation (Fiocruz) and of the Getulio Vargas Foundation (FGV) has just released a report on the risk of Covid-19 dissemination among indigenous populations, due to the geographic and sociodemographic vulnerability of this segment of the Brazilian population. According to the study, the arrival of Covid-19 has imposed many challenges to indigenous communities, to health authorities and to society as a...
Notícias
Data de publicação: 17/04/2020 - 14:29
Enhancing the actions of the Oswaldo Cruz Foundation (Fiocruz) in the view of the new coronavirus pandemic (Sars-CoV-2) by joining the forces of the public and private sectors. This is the goal of the United against Covid-19 program launched by Fiocruz on April 2nd, opening a channel for companies, organizations and individuals interested in being a part of the network of supporters for the initiatives developed by the institution, all over...
Notícias
Data de publicação: 15/04/2020 - 11:18
With the aim of presenting innovative initiatives to respond to the pandemic, researchers from the Foundation participated, on March 31, in a virtual workshop with Portuguese-speaking countries, organized by the Research Capacity Network (REDe) and the sharing knowledge base incorporated into the online platform The Global Health Network, from the University of Oxford. The platform aims to provide research resources, courses and other tools...
Notícias
Data de publicação: 14/04/2020 - 14:25
On this Tuesday, April 14th is celebrated for the first time as the World Chagas Day, after being recognized in 2019 by the World Health Organization (WHO). To mark the day that remembers the first case diagnosed in humans by Fiocruz researcher Carlos Chagas, in 1909, leaders of Global Health have prepared a video.
It is estimated that 6 to 7 million people worldwide suffer from Chagas disease, between 2 and 3 million of them live in Brazil....
Notícias
Data de publicação: 14/04/2020 - 09:51
The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the WHO and Fiocruz, the unit will now begin making confirmatory tests for the disease in the region, and will also join the WHO network of laboratory specialists for Covid-19.
National...
Notícias
Data de publicação: 09/04/2020 - 16:00
A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening of the clinical symptoms of the disease. Specialists have also looked into the combined use of atazanavir and ritonavir, another drug used to fight HIV.
The study was published this Monday (April 6) on...
Notícias
Data de publicação: 06/04/2020 - 12:38
Fiocruz president, Nísia Trindade Lima, attended last Wednesday (April 1st) a meeting of global health leaders requested by the director-general of the World Health Organization, Tedros Adhanom. The goal of the meeting was to discuss the advancement of control measures in different countries, share lessons learned, and, mainly, debate future challenges involving the Covid-19 pandemic.
The role of WHO in a post-quarantine transition was...
Notícias
Data de publicação: 06/04/2020 - 12:19
Fiocruz is now part of a group of more than 70 scientists and institutions of more than 30 countries in an international coalition to face the Covid-19 epidemic in countries with medium and low income. Launched last Thursday (02/04), the initiative, called Covid-19 Clinical Resarch Coalition, aims to speed up research on the new coronavirus in the areas where the virus may cause serious problems in health systems that are already fragile,...
Notícias
Data de publicação: 31/03/2020 - 14:34
The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit will have 200 beds exclusive for intensive and semi-intensive treatment of critical patients infected with the novel coronavirus (Sars-CoV-2). Check out a 3D view here.
Built in...
Notícias
Data de publicação: 31/03/2020 - 13:18
On March 24, the Oswaldo Cruz Foundation launched an express approval process at the Brazilian Registry of Clinical Essays (ReBEC) for clinical research on the Covid-19. The so-called fast track may reduce the normal approval period, which normally takes up to a couple of weeks, to less than 48 hours. Scientists all over the world will be able to have quick access to the modeling of ongoing studies, thus avoiding re-working and...
Notícias
Data de publicação: 31/03/2020 - 12:52
In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the institution as a response to this public health crisis, from the production of tests to health care to those infected. All departments and units of the Foundation are mobilized to face the epidemics....
Notícias
Data de publicação: 30/03/2020 - 14:04
An unprecedented study, conducted by the research group on Health in the Prisions [Saúde nas Prisões] of the National School of Public Health (Ensp/Fiocruz), and coordinated by Alexandra Sánchez, through technical cooperation with the Public Prosecutor's Office/RJ, analyzed the causes of deaths in the Prison System of the State of Rio de Janeiro (2016-2017). The results indicate that infectious diseases were...
Notícias
Data de publicação: 30/03/2020 - 11:09
Articles on the new coronavirus (Sars-CoV-2) can be published in just 24 hours in the journal Memórias do Instituto Oswaldo Cruz, one of the oldest and most respected scientific journals in Latin America.
Considering the importance of rapid data sharing during the pandemic, the journal provided an express way for the dissemination of research. Already used for work on Zika, chikungunya, yellow fever and Ebola, the Fast Track system...
Notícias
Data de publicação: 20/03/2020 - 13:24
The emergence of SARS-Cov-2 virus in Wuhan, China, in December 2019 led to a local epidemic that rapidly spread to multiple countries in the world, placing remarkable challenges in surveillance and control. On March 16th, 2020, WHO declared1 that the infection associated with SARS-Cov-2, named COVID-19, had spread to more than 100 countries, with more than 160,000 confirmed cases and more than 6,000 deaths globally.
Great uncertainty...
Notícias
Data de publicação: 19/03/2020 - 14:18
The Oswaldo Cruz Foundation (Fiocruz) will be sending a team of professionals to Portuguese-speaking countries in Africa to help organise the response to the new coronavirus pandemic. This cooperation answers to a request by the regional office of the World Health Organization (WHO) in Africa, received by Fiocruz last Sunday (March 15).
According to Fiocruz director of the Fiocruz Global Health Center, Paulo Buss, Brazilian and Portuguese...
Notícias
Data de publicação: 17/03/2020 - 13:56
Ten out of ten infectologists in the planet believe that one of the basic actions to avoid contamination by the Covid-19, more commonly known as coronavirus, is to stay away from large groups of people. This has led to the cancellation of numerous events such as sports events, concerts, conventions, and lessons in schools and universities. Even the healthy habit of going to the cinema has turned into a risky action. Now, what happens when you...
Notícias
Data de publicação: 16/03/2020 - 16:39
Health inequalities and challenges that science is facing nowadays were the common thread for the inaugural lecture for class 2020 at the Fiocruz National School of Public Health, held on March 4. Dr. Deisy Ventura, professor at the Faculty of Public Health of the University of São Paulo, was one of the main speakers in the event, which also had presentations from demographer Paulo Jannuzzi, from the Brazilian Institute of Geography and...
Notícias
Data de publicação: 03/03/2020 - 11:33
Given the emergence of agents with the capacity to cause diseases in humans, such as the new coronavirus, the Covid-19, scientists from all over the world have begun to work hard on the search for answers on the behavior of the pathogen. The process is similar to assembling a jigsaw puzzle: at every new research, an increasingly robust set of data takes form, contributing to clarify important characteristics that are crucial to create an...
Notícias
Data de publicação: 20/02/2020 - 14:09
Professors and researchers may apply for the scholarships under the Institutional Internationalization Program - PrInt Fiocruz-Capes. There are open selections for PhDs with Experience Abroad and for Visiting professor.
The PhD with Experience Abroad aims to attract researchers with experience in a foreign country to work at Fiocruz, whose training and professional experience represent an innovative contribution to the Fiocruz Graduate...
Notícias
Data de publicação: 19/02/2020 - 15:55
A research by Fiocruz Minas has shown that Lamp, the test used to detect a series of infectious diseases, can also be used to diagnose human visceral leishmaniasis. The study by the PCPP, the Group of Clinical Researches and Public Policies on Infectious and Parasitic Diseases, was recently published in the BioMed Research International magazine.
To verify the efficacy of the Lamp test, the researchers used the technique on blood samples that...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
